跳至主要内容
临床试验/NCT01254552
NCT01254552已完成4 期

Assessment With Cardiac Computed Tomography Angiography (CCTA) and Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

Guerbet1 个研究点 分布在 1 个国家目标入组 351 人开始时间: 2010年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Guerbet
入组人数
351
试验地点
1
主要终点
Prevalence of Occult Myocardial Scar on Delayed-enhanced MRI in Asymptomatic Patients With Type 2 Diabetes Mellitus

研究概览

简要总结

The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).

详细描述

Patients underwent a cardiac MRI examination with Dotarem within 60 days after screening visit. The myocardial CCTA examination with Xenetix 350 was performed within 1 to 30 days (but no sooner than 24 hours) after the MRI examination.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with onset of type 2 diabetes occurred at age 30 years or older
  • Patient between the ages of 50 and 75 years at enrolment time
  • Patient with at least two identified cardiac risk factors who will undergo a CMR and a CCTA examinations to evaluate his/her coronary and cardiac status

排除标准

  • Patient with angina pectoris or chest discomfort
  • Patient with stress test or invasive coronary angiography within the prior 3 years
  • Patient with history of myocardial infarction, overt non compensated heart failure, or coronary revascularization
  • Patient with hemodynamic instability.
  • Patient with a contraindication or intolerance to Beta-Blocker administration

研究组 & 干预措施

Dotarem and Xenetix 350

Experimental

干预措施: iobitridol (Drug)

Dotarem and Xenetix 350

Experimental

干预措施: gadoterate meglumine (Drug)

结局指标

主要结局

Prevalence of Occult Myocardial Scar on Delayed-enhanced MRI in Asymptomatic Patients With Type 2 Diabetes Mellitus

时间窗: From 1 week to 2 months (after the collection of data corresponding to cardiac MRI and CCTA examinations)

次要结局

  • Number of Patients With and Without Occult Myocardial Scar on Cardiac MRI According to the Degree of Stenosis(From 1 week to 2 months (after the collection of data corresponding to cardiac MRI and CCTA examinations))

研究者

发起方
Guerbet
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验